John P. Butler - CEO and President, Director at Akebia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Issuer Symbol
AKBA on Nasdaq
All Insider Reports
All Insider Reports

John P. Butler - trading volume in the past year for Akebia Therapeutics, Inc.

Holdings reported by John P. Butler for Akebia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,367,064 $4,208,830 $1.25 04 Mar 2026 Direct
Common Stock 159,928 $225,498 $1.41 04 Mar 2026 Held by Dorothy Butler Revocable Trust November 20, 2007
Stock Option (Right to buy) 1,115,000 30 Jan 2026 Direct Common Stock

Transactions reported by John P. Butler for Akebia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.